Archives

Signal Boost 2026

Signal Boost 2026 Second week of January. Year of the Horse. Back in the saddle. As I point my GPS toward a familiar constellation of pursuits, here’s a topline look at what I’m watching and where I think the music business is headed in 2026. These aren’t predictions, they’re signals. More from Spin: Bruno Mars […]

What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?

Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ~3.9% net of fees and expenses. In comparison, the SP500TR and R2000 returned approximately 2.7% and 2.2%, respectively, in the quarter, and finished the year up by 17.9% and […]

Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli

Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli Fermentation doi: 10.3390/fermentation12010053 Authors: Sushmita R. Kumar Esha Shukla Gaurav Pandey Glucagon-like peptide-1 (GLP-1) is an incretin hormone and therapeutic agent for Type II diabetes mellitus. However, recombinant production in E. coli yields insufficient […]

The Biological Cost of Ozempic and Other GLP-1s

Get the Highest Quality Electrolyte https://euvexia.com . Losing belly fat is hard so you may wonder if a GLP-1 will work. The question isn’t whether GLP-1s drugs like Ozempic or Wegovy work. It’s whether the long-term biology works the same afterward. That distinction changes everything. 🔴Blood Work Course https://www.drekberg.shop/products/ultimate-blood-work-course-by-dr-sten-ekberg 🔴 MASTER YOUR HEALTH BY SUBSCRIBING […]

Glucagon-like peptide-1 medicines and cancer

Nature Cancer, Published online: 16 January 2026; doi:10.1038/s43018-025-01110-1 Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer incidence, development and therapy and speculate about their mechanism on cancer cells and the tumor microenvironment.

Weight-loss drugs may trigger the next restaurant crisis

Chad Finkelstein is a partner at the law firm of Dale & Lessmann LLP and chair of the firm’s franchising, licensing and distribution group. His clients include U.S. and Canadian franchisors. Survey quick-service restaurants right now and you’ll likely hear a version of the same story: Customers are still coming in, but they’re ordering less. […]

Oprah Winfrey Recalls When Joan Rivers Fat-Shamed Her

Oprah Winfrey is no stranger to the limelight or public scrutiny. But her negative experience with the late Joan Rivers is still something that sticks in her memory. And now she’s getting candid about it. As you may have heard by now, Winfrey recently released her book—”Enough: Your Health, Your Weight, and What It’s Like […]